The Meaning of Dopaminergic Pathway in Sleep Breathing Disorders.

Enrolling by invitationOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Sleep ApneaSleep-Disordered Breathing
Interventions
DIAGNOSTIC_TEST

Polysomnography

Each of the patients will undergo polysomnography

DIAGNOSTIC_TEST

Blood dopamine level measurement

In each of the patients blood dopamine level will be measured

DIAGNOSTIC_TEST

Genetical test

Each of the patients will undergo genetical test focusing on selected single nucleotide polymorphisms within genes regulating the concentration of dopamine - the gene responsible for production of the enzyme catechol-O-methyltransferase (COMT) - rs4680 and rs6269 and genes encoding receptors dopamine (DRD1 - rs686, rs5327 and DRD2 - rs1800497).

Trial Locations (1)

Unknown

Wroclaw Medical Uniwesity, Wroclaw

All Listed Sponsors
lead

Wroclaw Medical University

OTHER